methylene blue has been researched along with oxyntomodulin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lippa, CF; Ozudogru, SN | 1 |
1 review(s) available for methylene blue and oxyntomodulin
| Article | Year |
|---|---|
Disease modifying drugs targeting β-amyloid.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Enzyme Inhibitors; Glucagon-Like Peptides; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Methylene Blue; Nootropic Agents | 2012 |